bf/NASDAQ:ALEC_icon.jpeg

COM:ALECTOR

Alector, Inc.

  • Stock

Last Close

5.24

07/11 21:00

Market Cap

483.85M

Beta: -

Volume Today

757.09K

Avg: -

  • locale

    usUnited States
  • market

    STOCKS
  • industry

    Biopharmaceutical
  • website

    alector.com
  • crunchbase

    alector
  • linkedin

    alector
  • founding date

    Jan 01, 2013
  • ipo date

    Feb 07, 2019

Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis diseases; and AL101 that is in Phase ...Show More

competitor of